Pacira Biosciences, Inc. (PCRX)
24.51
-0.85
(-3.35%)
USD |
NASDAQ |
Apr 24, 16:00
24.50
-0.01
(-0.04%)
After-Hours: 20:00
Pacira Biosciences Market Cap : 992.41M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Stryker Corp. | 125.33B |
| ACADIA Pharmaceuticals, Inc. | 3.744B |
| Alnylam Pharmaceuticals, Inc. | 40.52B |
| Savara, Inc. | 1.048B |
| BioMarin Pharmaceutical, Inc. | 10.23B |
Market Cap Related Metrics
| PE Ratio | 156.02 |
| PS Ratio | 1.514 |
| Price to Book Value | 1.432 |
| Price to Free Cash Flow | 8.045 |
| Price | 24.51 |
| Earnings Yield | 0.64% |
| Operating PE Ratio | 32.67 |
| Normalized PE Ratio | 61.86 |